SCHEMBL6184523

SCHEMBL6184523

O=C(O)c1cc(-c2ccc(C(F)(F)F)cc2)nc2cc(C(F)(F)F)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A1 P60842 1/20 0.58
DHODH Q02127 9/20 0.57
KDM4E B2RXH2 2/20 0.56
PDE10A Q9Y233 2/20 0.56
LMNA P02545 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
POLB P06746 2/20 0.55
HIF1A Q16665 2/20 0.53
HSD17B10 Q99714 2/20 0.53
TP53 P04637 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
ALDH1A1 P00352 3/20 0.51
PTGES O14684 1/20 0.51
ALOX5 P09917 1/20 0.51
CYP2C9 P11712 1/20 0.51
HPGD P15428 1/20 0.51
CASP7 P55210 1/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6181595 0.90 ALDH1A1 (0.59) DHODHKDM4EPDE10ALMNASMN1; SMN2
SCHEMBL116029 0.89 DHODH (0.74) DHODHKDM4EPDE10ALMNASMN1; SMN2
SCHEMBL30485644 0.84 AURKA (0.58) EIF4A1DHODHKDM4EPDE10ALMNA
SCHEMBL22573242 0.84 AURKA (0.58) EIF4A1DHODHKDM4EPDE10ALMNA
SCHEMBL6185429 0.84 ALDH1A1 (0.70) DHODHKDM4EPDE10ALMNASMN1; SMN2
SCHEMBL4251010 0.83 DHODH (0.61) DHODHKDM4EPDE10ALMNASMN1; SMN2
SCHEMBL29893763 0.82 ESR1 (0.50) EIF4A1DHODHKDM4EPDE10APOLB
SCHEMBL23590326 0.82 DHODH (0.67) DHODHHIF1AHSD17B10TP53CYP1A2
SCHEMBL29617663 0.82 DHODH (0.67) DHODHHIF1AHSD17B10TP53CYP1A2
SCHEMBL23590028 0.81 DHODH (0.62) DHODHKDM4EHIF1AHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
CN-1642599-A ACC inhibitors PFIZER PROD INC (US) 2005-07-20 CN disclosed
EP-1478437-A1 ACC INHIBITORS Pfizer Products Inc. (US) 2004-11-24 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed
WO-2003072197-A1 ACC INHIBITORS PFIZER PRODUCTS INC. (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 EIF4A1 2733/4885DHODH 783/4885KDM4E 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.